Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 288

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 288
---
                      Chief Executive Officer  

ALPHA TAU MEDICAL LTD. AND ITS SUBSIDIARIES

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2024

INDEX

  Reports of Independent Registered Public Accounting Firm (PCAOB ID: 1281)                          F-2         
  Consolidated Balance Sheets                                                                        F-3 - F-4   
  Consolidated Statements of Operations                                                              F-5         
  Consolidated Statements of Convertible Preferred Shares and Shareholders’ (Deficiency) Equity      F-6         
  Consolidated Statements of Cash Flows                                                              F-7         
  Notes to Consolidated Financial Statements                                                         F-8 - F-32  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                                                                                     Page        

- - - - - - - - - - -

F-1

  Kost Forer Gabbay &           Tel: +972-3-6232525  

REPORT OF INDEPENDENT AUDITORS

To the Shareholders and Board of Directors of

ALPHA TAU MEDICAL LTD.

Opinion on the Financial Statements

We have audited the accompanying
consolidated balance sheets of Alpha Tau Medical Ltd. and its subsidiaries (the “ Company”) as of December 31, 2023 and 2024,
the related consolidated statements of operations, Convertible Preferred shares and shareholders’ (deficiency) equity and cash flows for
each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the “consolidated
financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial
position of the Company at December 31, 2023 and 2024, and the results of its operations and its cash flows for each of the three years
in the period ended December 31, 2024, in conformity with U. S. generally accepted accounting principles.

Basis for Opinion

These financial statements are
the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements
based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“ PCAOB”)
and are required to be independent with respect to the Company in accordance with the U. S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.